1. Home
  2. TIL vs GAUZ Comparison

TIL vs GAUZ Comparison

Compare TIL & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • GAUZ
  • Stock Information
  • Founded
  • TIL 2018
  • GAUZ 2009
  • Country
  • TIL United States
  • GAUZ Israel
  • Employees
  • TIL N/A
  • GAUZ N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • GAUZ Industrial Machinery/Components
  • Sector
  • TIL Health Care
  • GAUZ Miscellaneous
  • Exchange
  • TIL Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • TIL 171.7M
  • GAUZ 184.0M
  • IPO Year
  • TIL 2021
  • GAUZ 2024
  • Fundamental
  • Price
  • TIL $13.23
  • GAUZ $9.75
  • Analyst Decision
  • TIL Buy
  • GAUZ Strong Buy
  • Analyst Count
  • TIL 5
  • GAUZ 4
  • Target Price
  • TIL $114.00
  • GAUZ $16.25
  • AVG Volume (30 Days)
  • TIL 180.4K
  • GAUZ 52.7K
  • Earning Date
  • TIL 05-20-2025
  • GAUZ 05-13-2025
  • Dividend Yield
  • TIL N/A
  • GAUZ N/A
  • EPS Growth
  • TIL N/A
  • GAUZ N/A
  • EPS
  • TIL N/A
  • GAUZ N/A
  • Revenue
  • TIL N/A
  • GAUZ $103,527,000.00
  • Revenue This Year
  • TIL N/A
  • GAUZ $32.83
  • Revenue Next Year
  • TIL N/A
  • GAUZ $42.86
  • P/E Ratio
  • TIL N/A
  • GAUZ N/A
  • Revenue Growth
  • TIL N/A
  • GAUZ 32.76
  • 52 Week Low
  • TIL $9.62
  • GAUZ $6.78
  • 52 Week High
  • TIL $92.00
  • GAUZ $17.10
  • Technical
  • Relative Strength Index (RSI)
  • TIL 44.22
  • GAUZ N/A
  • Support Level
  • TIL $11.97
  • GAUZ N/A
  • Resistance Level
  • TIL $14.67
  • GAUZ N/A
  • Average True Range (ATR)
  • TIL 2.05
  • GAUZ 0.00
  • MACD
  • TIL -0.04
  • GAUZ 0.00
  • Stochastic Oscillator
  • TIL 17.87
  • GAUZ 0.00

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

Share on Social Networks: